Ranbaxy and Pfenex team up to develop a biosimilar therapeutic protein
Ranbaxy Laboratories and San Diego-based Pfenex Inc. have announced that Ranbaxy will develop an undisclosed biosimilar therapeutic produced in Pfenex’s expression technology platform
To continue reading this article, subscribe for FREE to
Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.
About the Author
- This person does not yet have a bio.
